RSS Feed
Bladder Cancer News & Articles
Wed 17th Oct 12
US Laboratory complete– regulatory approval process underway
NZX ANNOUNCEMENT: Released 17 October 2012
Cancer diagnostic company Pacific Edge Limited has completed its US$3.7 million laboratory in the United States on-schedule and within budget and is now preparing for registration under the Clinical Laboratory Improvement Amendments (CLIA) regulations.
...Read More
Added by: Cxbladder Team
Tue 28th Aug 12
Summary of Chief Executive's presentation to the Annual Shareholder Meeting held in Dunedin on 23 August 2012
NZX ANNOUNCEMENT: Released 27 August 2012
Key points:
The roll out of Cxbladder® in the USA and commissioning of purpose built laboratory testing centre in Hershey, Pennsylvania proceeding on schedule and to budget.
Interest in Cxbladder® from urologists, general practitioners and me...Read More
Added by: Cxbladder Team
Fri 17th Aug 12
Cxbladder® exhibiting at NZ GP CME South Conference
Pacific Edge Ltd is currently exhibiting Cxbladder® at the 2012 GP CME South Conference in Dunedin, New Zealand. The conference is being held at the Edgar Centre and will run until Sunday the 19th of August.
If you are attending the conference, come by and meet the team at Stand 55.
Added by: Cxbladder Team
NZX ANNOUNCEMENT: Released 6 August 2012
The prestigious American Journal of Urology has published further evidence that confirms theeffectiveness of Pacific Edge’s Cxbladder® test for detecting bladder cancer.
The peer reviewed scientific paper has been published by the Journal online a...Read More
Added by: Cxbladder Team
NZX ANNOUNCEMENT: Released 29 June 2012
Key customers in the United States are already being primed for the launch of Pacific Edge’s novel diagnostic test for bladder cancer, Cxbladder® on track for March 2013.
The commercial launch in the US of the non-invasive test, for bladder cance...Read More
Added by: Cxbladder Team
NZTE Media Writer, Katherine Edmond used Pacific Edge Limited as a case study “demonstrating the learnings and experiences of New Zealand businesses exporting to or operating in the United States.”
Pacific Edge Limited
It took three years immersion in the United States market place and...Read More
Added by: Cxbladder Team
Mon 7th May 12
Oryzon to Present its LSD1 program in Acute Leukemias at the GTC’s 2nd Epigenetics in Drug Discovery conference in Boston
Barcelona, May 7th, 2012. Oryzon announced today that Dr. Tamara Maes will present the latest advances of its LSD1 program in hematological malignancies at GTC’s 2nd Epigenetics in Drug Discovery conference in the session Drug Discovery in Epigenetics: on May 30-31 at the Hyatt Harbors...Read More
Added by: Cxbladder Team